Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Find Which Dividend Etf Is Best Value by assessing cost, diversification, and proven performance across the dividend ETF landscape.
25,553 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Moscow has launched a limited, state-backed crypto settlement corridor for select foreign-trade partners, testing ho...
A new manufacturing revival gains momentum, led by Atomic Industries and its CEO. The plan envisions a 100-year build...
Circle Internet Group stock is edging higher as investors digest new signals from insiders and the evolving crypto-re...
AI-driven momentum is sweeping through workplaces and markets, yet the official data trail remains far behind. Econom...
Meta leans on ad-driven growth and in-house AI monetization to push margins higher, while Intel navigates heavy capex...
Rivian’s quality metrics, limited service footprint, and steep pricing are prompting investor caution in 2026. This r...
A controversial proposal has sparked a fierce debate among developers, miners, and industry leaders. This article unp...
When a CEO sells shares, investors watch closely. This piece breaks down Exponent's move by Catherine Corrigan, expla...
If you think it's late Vertiv, you're not alone. Yet the data-center and AI infrastructure cycle still offers upside....
A fresh AI-driven marketing platform launches a Reg A+ offering at $0.85 per share, claiming strong ROI through AI-po...
Anthropic’s Dario Amodei says culture matters more than code in winning the AI race, dedicating up to 40% of his time...